拉莫三嗪治疗儿童期顽固性缺乏症和全身性强直-阵挛性癫痫的显著效果

Tally Lerman-Sagie , Pinchas Lerman
{"title":"拉莫三嗪治疗儿童期顽固性缺乏症和全身性强直-阵挛性癫痫的显著效果","authors":"Tally Lerman-Sagie ,&nbsp;Pinchas Lerman","doi":"10.1016/S0896-6974(97)00133-3","DOIUrl":null,"url":null,"abstract":"<div><p><span>The purpose of this study was to evaluate the efficacy of adding lamotrigine to </span>valproic acid<span> in patients with refractory absence seizures starting in childhood and persisting into adulthood. Lamotrigine was added to previous anticonvulsants (always including valproic acid) in 10 patients aged 23–44 years, with intractable absence and generalized tonic–clonic seizures. Seven patients became seizure free, three patients had &gt; 75% reduction in seizure frequency. The patients have remained on comedication with valproic acid and lamotrigine, after gradually discontinuing most other anticonvulsants, for a follow-up period ranging from 1–4 years. There has been no increase in seizure frequency during this period. None of the patients reported any side effects. This study supports the growing evidence of therapeutic synergy between lamotrigine and valproic acid. This combination may be the therapy of choice for refractory absence and generalized tonic–clonic seizures both in children and adults.</span></p></div>","PeriodicalId":81656,"journal":{"name":"Journal of epilepsy","volume":"11 3","pages":"Pages 148-151"},"PeriodicalIF":0.0000,"publicationDate":"1998-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0896-6974(97)00133-3","citationCount":"7","resultStr":"{\"title\":\"Dramatic Effect of Lamotrigine in Young Adults Suffering from Intractable Absences and Generalized Tonic–Clonic Seizures Since Childhood\",\"authors\":\"Tally Lerman-Sagie ,&nbsp;Pinchas Lerman\",\"doi\":\"10.1016/S0896-6974(97)00133-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span>The purpose of this study was to evaluate the efficacy of adding lamotrigine to </span>valproic acid<span> in patients with refractory absence seizures starting in childhood and persisting into adulthood. Lamotrigine was added to previous anticonvulsants (always including valproic acid) in 10 patients aged 23–44 years, with intractable absence and generalized tonic–clonic seizures. Seven patients became seizure free, three patients had &gt; 75% reduction in seizure frequency. The patients have remained on comedication with valproic acid and lamotrigine, after gradually discontinuing most other anticonvulsants, for a follow-up period ranging from 1–4 years. There has been no increase in seizure frequency during this period. None of the patients reported any side effects. This study supports the growing evidence of therapeutic synergy between lamotrigine and valproic acid. This combination may be the therapy of choice for refractory absence and generalized tonic–clonic seizures both in children and adults.</span></p></div>\",\"PeriodicalId\":81656,\"journal\":{\"name\":\"Journal of epilepsy\",\"volume\":\"11 3\",\"pages\":\"Pages 148-151\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1998-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/S0896-6974(97)00133-3\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of epilepsy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0896697497001333\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of epilepsy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0896697497001333","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

摘要

本研究的目的是评价在丙戊酸中加入拉莫三嗪治疗儿童期开始并持续到成年期的难治性癫痫发作的疗效。10例年龄23-44岁的顽固性缺席和全身性强直-阵挛性癫痫患者在既往抗惊厥药物(总是包括丙戊酸)的基础上加入拉莫三嗪。7例患者癫痫消失,3例患者癫痫发作;癫痫发作频率降低75%。患者在逐渐停用大多数其他抗惊厥药物后,仍继续服用丙戊酸和拉莫三嗪,随访时间为1-4年。在此期间,癫痫发作频率没有增加。没有患者报告有任何副作用。这项研究支持了拉莫三嗪和丙戊酸之间治疗协同作用的越来越多的证据。这种组合可能是儿童和成人难治性缺席和全身性强直-阵挛性癫痫发作的治疗选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Dramatic Effect of Lamotrigine in Young Adults Suffering from Intractable Absences and Generalized Tonic–Clonic Seizures Since Childhood

The purpose of this study was to evaluate the efficacy of adding lamotrigine to valproic acid in patients with refractory absence seizures starting in childhood and persisting into adulthood. Lamotrigine was added to previous anticonvulsants (always including valproic acid) in 10 patients aged 23–44 years, with intractable absence and generalized tonic–clonic seizures. Seven patients became seizure free, three patients had > 75% reduction in seizure frequency. The patients have remained on comedication with valproic acid and lamotrigine, after gradually discontinuing most other anticonvulsants, for a follow-up period ranging from 1–4 years. There has been no increase in seizure frequency during this period. None of the patients reported any side effects. This study supports the growing evidence of therapeutic synergy between lamotrigine and valproic acid. This combination may be the therapy of choice for refractory absence and generalized tonic–clonic seizures both in children and adults.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信